3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rhabdomyosarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Multiple Endocrine Neoplasia Type 2a
1
Medulloblastoma
1
Lethal Congenital Contracture Syndrome 2
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
15
Cisplatin
13
durvalumab
12
pembrolizumab
10
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Biopsy
7
Specimen Handling
6
Leucovorin
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
futibatinib
3
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
lenvatinib
2
fludarabine
2
dehydroftorafur
2
Radiation Dose Hypofractionation
2
Platinum
2
Liver Transplantation
2
Fluorodeoxyglucose F18
2
Floxuridine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Vascular Endothelial Growth Factor A
×
90 days
×
Clear all
No trials found.